Neuberger Berman Group
ATRC icon

Neuberger Berman Group’s AtriCure ATRC Stock Holding History

Neuberger Berman Group’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6M Sell
947,982
-102,300
-10% -$2.88M 0.02% 647
2026
Q1 		$30M Sell
1,050,282
-36,044
-3% -$1.23M 0.02% 578
2025
Q4 		$43M Sell
1,086,326
-104,785
-9% -$3.84M 0.03% 499
2025
Q3 		$42M Buy
1,191,111
+1,372
+0.1% +$47.3K 0.03% 505
2025
Q2 		$39M Buy
1,189,739
+3,674
+0.3% +$119K 0.03% 496
2025
Q1 		$38.4M Buy
1,186,065
+246,877
+26% +$9.16M 0.03% 489
2024
Q4 		$28.7M Sell
939,188
-2,947
-0.3% -$94.8K 0.02% 571
2024
Q3 		$26.4M Buy
942,135
+73,698
+8% +$1.82M 0.02% 590
2024
Q2 		$19.8M Buy
868,437
+80,464
+10% +$1.86M 0.02% 640
2024
Q1 		$24M Sell
787,973
-730,469
-48% -$24.5M 0.02% 605
2023
Q4 		$54.3M Buy
1,518,442
+754,425
+99% +$28.1M 0.02% 543
2023
Q3 		$33.5M Buy
764,017
+3,276
+0.4% +$160K 0.03% 484
2023
Q2 		$37.6M Buy
760,741
+7,072
+0.9% +$326K 0.03% 474
2023
Q1 		$31.2M Buy
753,669
+204,175
+37% +$8.47M 0.03% 524
2022
Q4 		$24.4M Buy
549,494
+7,008
+1% +$293K 0.02% 571
2022
Q3 		$21.2M Buy
542,486
+32,226
+6% +$1.47M 0.02% 598
2022
Q2 		$20.8M Buy
510,260
+18,889
+4% +$895K 0.02% 616
2022
Q1 		$32.2M Sell
491,371
-11,909
-2% -$772K 0.03% 569
2021
Q4 		$34.4M Buy
503,280
+364
+0.1% +$26.5K 0.03% 569
2021
Q3 		$34.4M Sell
502,916
-8,420
-2% -$648K 0.03% 556
2021
Q2 		$40.1M Sell
511,336
-129,031
-20% -$9.38M 0.04% 525
2021
Q1 		$41.6M Sell
640,367
-71,582
-10% -$4.41M 0.04% 489
2020
Q4 		$39.4M Sell
711,949
-21,981
-3% -$950K 0.04% 460
2020
Q3 		$29.2M Sell
733,930
-11,052
-1% -$469K 0.03% 481
2020
Q2 		$33.5M Sell
744,982
-100,073
-12% -$4.36M 0.04% 441
2020
Q1 		$28.3M Sell
845,055
-7,083
-0.8% -$255K 0.04% 432
2019
Q4 		$27.7M Buy
852,138
+91,059
+12% +$2.59M 0.03% 517
2019
Q3 		$19M Buy
761,079
+36,473
+5% +$1.04M 0.02% 592
2019
Q2 		$21.6M Sell
724,606
-7,821
-1% -$228K 0.03% 580
2019
Q1 		$19.6M Buy
732,427
+7,597
+1% +$231K 0.02% 612
2018
Q4 		$22.2M Sell
724,830
-11,499
-2% -$358K 0.03% 536
2018
Q3 		$25.8M Sell
736,329
-24,197
-3% -$766K 0.03% 571
2018
Q2 		$20.6M Sell
760,526
-19,339
-2% -$454K 0.02% 627
2018
Q1 		$16M Sell
779,865
-36,659
-4% -$662K 0.02% 676
2017
Q4 		$14.9M Sell
816,524
-83,772
-9% -$1.66M 0.02% 703
2017
Q3 		$20.1M Buy
900,296
+75,827
+9% +$1.71M 0.03% 605
2017
Q2 		$20M Buy
824,469
+257,949
+46% +$5.48M 0.03% 604
2017
Q1 		$10.8M Buy
+566,520
New +$9.92M 0.01% 740

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Neuberger Berman Group's ATRC Position: Q2 2026 in Review

Neuberger Berman Group reduced its AtriCure (ATRC) stake by 9.7% in Q2 2026, selling an estimated $2.88M and leaving 947,982 shares worth $26.6M. The position accounts for 0.02% of the portfolio, ranked #647.

Neuberger Berman Group first reported a position in ATRC in Q1 2017 and has held it in 38 quarters since. The position peaked at $54.3M in Q4 2023. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Neuberger Berman Group held 947,982 shares of AtriCure worth $26.6M as of Q2 2026.
  • Neuberger Berman Group sold 102,300 AtriCure shares in Q2 2026, an estimated $2.88M.
  • AtriCure made up 0.02% of Neuberger Berman Group's portfolio in Q2 2026, its #647 holding.
  • Neuberger Berman Group first reported a position in AtriCure in Q1 2017 and has held it in 38 quarters since.
  • Neuberger Berman Group's AtriCure position peaked at $54.3M in Q4 2023.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.